Humankind Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $292K | Buy |
+896
| New | +$292K | 0.07% | 111 |
|
|
2024
Q3 | – | Sell |
-916
| Closed | -$223K | – | 142 |
|
|
2024
Q2 | $223K | Sell |
916
-616
| -40% | -$150K | 0.06% | 126 |
|
|
2024
Q1 | $229K | Buy |
1,532
+262
| +21% | +$39.2K | 0.06% | 124 |
|
|
2023
Q4 | $243K | Buy |
1,270
+128
| +11% | +$24.5K | 0.07% | 119 |
|
|
2023
Q3 | $202K | Buy |
1,142
+29
| +3% | +$5.14K | 0.08% | 111 |
|
|
2023
Q2 | $211K | Buy |
+1,113
| New | +$211K | 0.08% | 116 |
|